Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

NCT03367572 is registered in ClinicalTrials.gov with University of Rochester NCORP Research Base as lead sponsor.

NCT NCT03367572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Lead sponsor
University of Rochester NCORP Research Base
Phase
Phase 3
Overall status
Completed
Start date
April 19, 2018
Completion date
April 13, 2024
Enrollment
1,363 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma